Autoimmune and Inflammatory Responses May Have an Additive Effect in Postpercutaneous Transluminal Coronary Angioplasty Restenosis
- 1 February 1998
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 81 (3) , 339-341
- https://doi.org/10.1016/s0002-9149(97)00914-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Production of C-reactive protein and risk of coronary events in stable and unstable anginaThe Lancet, 1997
- Anti-Cardiolipin Antibodies and Risk of Myocardial Infarction in a Prospective Cohort of Middle-Aged MenCirculation, 1995
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Antiphospholipid antibodies and cardiovascular disease.Heart, 1992
- A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) proteinJournal of Immunological Methods, 1991
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990
- CORONARY ARTERY BYPASS GRAFT FAILURE—AN AUTOIMMUNE PHENOMENON?The Lancet, 1986
- Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy.Circulation, 1985